tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

Activists and 5% owners

Schedule 13D filings from the last 90 days. A 13D is required within 10 days of crossing 5% of a company by anyone who does not hold it passively. Item 4 says what the owner intends: board seats, a sale, a buyback, or nothing in particular. Quoted as filed.

294 filings.

Aug 17, 2026 13D HWH Hwh International Inc. 94.8% of HWH's shares new stake, above 5%
Liu Ming Hui and 1 more reporting person · 180.00M shares · event Aug 10, 2026
Item 4, purpose of the transaction: This purchase of securities has resulted in a change of control for the Issuer. The Securities Purchase Agreement that set the terms of the transaction provided for the Purchaser to have the right to nominate three new directors to the Issuer's board of directors, who joined the Issuer's board of directors on August 10, 2026. The Reporting Persons may acquire or dispose of additional securities of Issuer from time to time.
Read the filing ↗
Aug 17, 2026 13D Pinnacle Acquisition Corp 26.9% of the shares new stake, above 5%
AVR Capital Holdings, LLC and 1 more reporting person · 6.97M shares · event Aug 10, 2026
Item 4, purpose of the transaction: In connection with the organization of the Issuer, on April 7, 2026, the Sponsor paid $25,000 to purchase 7,187,500 Class B Ordinary Shares (the "Founder Shares"), pursuant to a Securities Subscription Agreement, dated as of April 7, 2026, by and between the Sponsor and the Issuer (the "Founder Share Purchase Agreement"), as more fully described in Item 6 of this Schedule 13D which information is incorporated herein by reference. On July 21, 2026, the Sponsor surrendered 1,437,500 Founder Shares for no consideration and holds 5,750,000 Founder Shares. On August 10, 2026, simultaneously with the consummation of the IPO, the Sponsor purchased 225,000 units ("Placement Units") of the Issuer at …
Read the filing ↗
Aug 17, 2026 13D Pinnacle Acquisition Corp 23.0% of the shares new stake, above 5%
PAC Sponsor, LLC · 5.97M shares · event Aug 10, 2026
Item 4, purpose of the transaction: In connection with the organization of the Issuer, on April 7, 2026, the Sponsor paid $25,000 to purchase 7,187,500 Class B Ordinary Shares (the "Founder Shares"), pursuant to a Securities Subscription Agreement, dated as of April 7, 2026, by and between the Sponsor and the Issuer (the "Founder Share Purchase Agreement"), as more fully described in Item 6 of this Schedule 13D which information is incorporated herein by reference. On July 21, 2026, the Sponsor surrendered 1,437,500 Founder Shares for no consideration and holds 5,750,000 Founder Shares. On August 10, 2026, simultaneously with the consummation of the Issuer's Initial Public Offering (the "IPO"), the Sponsor purchased 225,000 un…
Read the filing ↗
Aug 17, 2026 13D Pinnacle Acquisition Corp 27.8% of the shares new stake, above 5%
Steven Kenneth Hudson · 7.22M shares · event Aug 10, 2026
Item 4, purpose of the transaction: In connection with the organization of the Issuer, on April 7, 2026, the Sponsor paid $25,000 to purchase 7,187,500 Class B Ordinary Shares (the "Founder Shares"), pursuant to a Securities Subscription Agreement, dated as of April 7, 2026, by and between the Sponsor and the Issuer (the "Founder Share Purchase Agreement"), as more fully described in Item 6 of this Schedule 13D which information is incorporated herein by reference. On July 21, 2026, the Sponsor surrendered 1,437,500 Founder Shares for no consideration and holds 5,750,000 Founder Shares. On August 10, 2026, simultaneously with the consummation of the IPO, the Sponsor purchased 225,000 units ("Placement Units") of the Issuer at …
Read the filing ↗
Aug 17, 2026 13D Latigo Biotherapeutics, Inc. 14.5% of the shares new stake, above 5%
Foresite Capital Fund VI LP and 6 more reporting persons · 9.18M shares · event Aug 10, 2026
Item 4, purpose of the transaction: The Reporting Persons hold their securities of the Issuer for investment purposes. Depending on the factors discussed herein, the Reporting Persons may, from time to time, acquire additional shares of Common Stock and/or retain and/or sell all or a portion of the Common Stock held by the Reporting Persons in the open market or in privately negotiated transactions, and/or may distribute the Common Stock held by the Reporting Persons to their respective members or limited partners. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons' review of numerous factors, including, among other things, the price levels of the Common Stock; general market and eco…
Read the filing ↗
Aug 17, 2026 13D FEMY Femasys Inc. 10.0% of FEMY's shares new stake, above 5%
Nantahala Capital Partners Limited Partnership and 3 more reporting persons · 803K shares · event Aug 10, 2026
Item 4, purpose of the transaction: The disclosure regarding the SPA and the Purchase set forth above in Item 3 is incorporated herein by reference. The Issuer has further described the SPA, the Purchase and the Side Letter in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the "SEC") on August 14, 2026. Pursuant to a side letter (the "Side Letter") entered into by Nantahala and the Issuer on August 7, 2026, for so long as Nantahala beneficially owns at least 15% of the outstanding shares of Common Stock (which determination shall be made without regard to the Beneficial Ownership Limitation), until the tenth anniversary of the Purchase, the board of directors (the "Board") of the Issuer s…
Read the filing ↗
Aug 17, 2026 13D JCTC Jewett-Cameron Trading Company Ltd 21.0% of JCTC's shares new stake, above 5%
Kotarba Partners Fund I, LP and 2 more reporting persons · 739K shares · event Aug 6, 2026
Item 4, purpose of the transaction: The Reporting Persons acquired the rights described in Item 3 for investment purposes. Scott Kotarba was appointed to the Issuer's board of directors (the "Board") effective August 10, 2026. As a member of the Board, Mr. Kotarba participates in the management and policies of the Issuer and, in that capacity, may take positions or actions with respect to matters presented to the Board. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may engage in discussions with the Issuer's management, the Board, other shareholders and other persons regarding the Issuer's business, operations, capital structure, strategy, governance and Board composition. Dep…
Read the filing ↗
Aug 14, 2026 13D Braveheart Bio, Inc. 11.4% of the shares new stake, above 5%
AH Bio Fund IV, L.P. and 3 more reporting persons · 10.23M shares · event Aug 7, 2026
Item 4, purpose of the transaction: The Reporting Persons purchased the aforementioned securities for investment purposes with the aim of increasing the value of their investments and the Issuer. Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to time in open market or private transactions, depending on its evaluation of the Issuer's business, prospects and financial condition, the market for the Issuer's securities, other developments concerning the Issuer, the reaction of the Issuer to the Reporting Persons' ownership of the Issuer's securities, other opportunities available to the Reporting Persons, and general economic, money market …
Read the filing ↗
Aug 14, 2026 13D VATE INNOVATE Corp. 7.4% of VATE's shares new stake, above 5%
Voigt Paul and 2 more reporting persons · 1.03M shares · event Aug 6, 2025
Item 4, purpose of the transaction: The shares and options described in Item 3(a) above were acquired by Mr. Voigt in connection with, and as compensation for, his service as an executive officer of the Issuer. The shares described in Item 3(b) above were acquired by the applicable Reporting Person for investment purposes, based on that Reporting Person's belief that the Common Stock represented an attractive investment. None of the acquisitions described in this Statement were made for the purpose of, or with the effect of, changing or influencing control of the Issuer. Except as set forth in this Statement, the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions or events…
Read the filing ↗
Aug 14, 2026 13D BGLC BioNexus Gene Lab Corp 11.5% of BGLC's shares new stake, above 5%
Tan Lee Su-Leng · 339K shares · event Aug 13, 2026
Item 4, purpose of the transaction: The Reporting Person acquired the shares as compensation for completed services to the Issuer and in connection with the Reporting Person's service as Chief Executive Officer and President and as a director. The shares were not acquired with borrowed funds or for the purpose of acquiring control of the Issuer. By reason of the Reporting Person's executive and Board positions, the Reporting Person participates in the management, business, policies and strategic direction of the Issuer and may from time to time consider, discuss or support actions concerning the Issuer's business, operations, governance, capital structure, securities, financing, acquisitions or dispositions, Board composition,…
Read the filing ↗
Aug 14, 2026 13D QVCCQ Qvc Group, Inc. 17.1% of QVCCQ's shares new stake, above 5%
GoldenTree Asset Management LP and 2 more reporting persons · 8.56M shares · event Aug 7, 2026
Item 4, purpose of the transaction: General The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake may be made at any time and from time to time without prior notice and will be dependent upon the Reporting Persons' review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments. The Reporting Persons may acquire additional securities of the Issuer, …
Read the filing ↗
Aug 14, 2026 13D Thunder Bridge Capital Partners V, Ltd. 20.8% of the shares new stake, above 5%
Tbcp V, LLC and 1 more reporting person · 7.95M shares · event Aug 14, 2026
Item 4, purpose of the transaction: In connection with the organization of the Issuer, on May 20, 2026, 7,503,750 Class B Ordinary Shares (the "Founder Shares") were purchased by the Sponsor for the amount of $25,000, pursuant to a Securities Subscription Agreement, dated as of May 19, 2026, by and between the Sponsor and the Issuer (the "Founder Share Purchase Agreement"), as more fully described in Item 6 of this Schedule 13D which information is incorporated herein by reference. On August 14, 2026, simultaneously with the consummation of the Issuer's Initial Public Offering (the "IPO"), the Sponsor purchased 447,000 units ("Placement Units") of the Issuer at $10.00 per Placement Unit, pursuant to a Private Placement Units P…
Read the filing ↗
Aug 14, 2026 13D LCLN Lincoln International, Inc. 31.2% of LCLN's shares new stake, above 5%
Lawrence James Lawson III and 4 more reporting persons · 16.27M shares · event Aug 12, 2026
Item 4, purpose of the transaction: General The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons' review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments. The Reporting Persons may acquire additional securities of the Issuer, or retain or sell all or a portion of the securities then held, in the …
Read the filing ↗
Aug 14, 2026 13D MDXH MDxHealth SA 33.2% of MDXH's shares new stake, above 5%
Bleichroeder LP and 2 more reporting persons · 31.65M shares · event Aug 11, 2026
Item 4, purpose of the transaction: Bleichroeder originally acquired beneficial ownership of Shares of the Issuer for investment purposes. On August 11, 2026, certain funds and entities managed by Bleichroeder (the "Funds") entered into securities purchase agreements with the Issuer (the "Securities Purchase Agreements") pursuant to which they purchased in the aggregate 24,229,074 Ordinary Shares (the "Purchased Shares") in a registered direct offering for a per-share purchase price of $0.454. On August 11, 2026, the Funds entered into a lock-up agreement (the "Lock-Up Agreement") with the Issuer pursuant to which, among other things, the Funds agreed not to sell, offer, pledge or otherwise dispose or transfer, or enter into…
Read the filing ↗
Aug 14, 2026 13D HGV Hilton Grand Vacations Inc. 6.5% of HGV's shares new stake, above 5%
CAS Investment Partners, LLC and 4 more reporting persons · 5.07M shares · event Aug 9, 2026
Item 4, purpose of the transaction: The shares of Common Stock of the Issuer covered by this statement were originally acquired in the ordinary course of business solely for investment purposes and not for the purposes of participating in or influencing the management of the Issuer. The shares of Common Stock of the Issuer covered by this statement were previously reported on Schedule 13G, originally filed by the Reporting Persons on February 14, 2022, as amended by the Schedule 13G/A filed by the Reporting Persons on February 14, 2023, and the Schedule 13G/A filed by the Reporting Persons on February 14, 2024. The Reporting Persons are filing this Schedule 13D to report that they have initiated communications and intend to co…
Read the filing ↗
Aug 14, 2026 13D APO Apollo Global Management 0.5% of APO's shares new stake, above 5%
Ldb 2025 LLC · 3.00M shares · event Aug 13, 2026
Item 4, purpose of the transaction: The information set forth under Item 3 above is incorporated by reference herein. Stockholders Agreement On August 13, 2026, the Reporting Person became a party to the Stockholders Agreement among the Issuer, Leon D. Black, Marc J. Rowan, Joshua J. Harris (each, a "Principal") and the other persons party thereto, dated as of January 1, 2022 (the "Stockholders Agreement"). The Stockholders Agreement provides that: o the Issuer will nominate each Principal (or his designee, as applicable) as part of the director slate of the Issuer's board of directors (the "Board"), for so long as such Principal, together with the members of his family group, beneficially owns at least $400 million in valu…
Read the filing ↗
Aug 13, 2026 13D MRAI Marpai, Inc. 9.3% of MRAI's shares new stake, above 5%
Calvin Steven Mitchell and 1 more reporting person · 1.95M shares · event Oct 30, 2025
Item 4, purpose of the transaction: The Reporting Persons believe that the Issuer is an attractive investment opportunity. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. In connection therewith, and with a view of enhancing shareholder value, the Reporting Persons and their respective representatives expect, from time to time, to engage in discussions with the Issuer's management and the board of directors of the Issuer (the "Issuer Board"), with other current or prospective shareholders and other third parties regarding business strategy, operating performance and corporate governance of the Issuer. The Reporting Persons may exchange information with the Issuer or other persons p…
Read the filing ↗
Aug 13, 2026 13D EWSB EWSB Bancorp, Inc. 9.9% of EWSB's shares new stake, above 5%
Spence Limited, LP and 1 more reporting person · 101K shares · event Jun 29, 2026
Item 4, purpose of the transaction: The shares covered by this Schedule 13D are being held for investment purposes. The Reporting Persons may, from time to time, acquire additional securities of the Issuer using personal funds through a broker and/or privately negotiated transactions or dispose of securities. The Reporting Persons filed an initial Schedule 13G on September 30, 2024. The Reporting Persons are filing this Schedule 13D to supersede the Schedule 13G. On July 1, 2026, Ms. Lundt was appointed to serve on the Boards of Directors of the Issuer and its wholly owned subsidiary, East Wisconsin Savings Bank. Ms. Lundt will engage in regular discussions with the Issuer's board of directors and management as part of her d…
Read the filing ↗
Aug 13, 2026 13D BlossomHill Therapeutics, Inc. 11.8% of the shares new stake, above 5%
Cormorant Global Healthcare Master Fund, LP and 9 more reporting persons · 3.62M shares · event Aug 6, 2026
Item 4, purpose of the transaction: The Reporting Persons acquired the securities reported herein for the benefit of the above-referenced private investment funds and accounts for investment purposes. The Reporting Persons intend to evaluate this investment in the Issuer and options with respect to such investment on an ongoing basis. The Reporting Persons may acquire additional Common Stock of the Issuer from time to time or may dispose of any or all of such Common Stock or other securities held or beneficially owned by them at any time. From time to time, the Reporting Persons may engage in discussions with the Issuer's Board of Directors and/or members of the Issuer's management team concerning, without limitation, po…
Read the filing ↗